Scholarlink

Background and hypothesis <p>Acute kidney injury (AKI) and chronic kidney disease (CKD) are associated with high morbidity. Current diagnostic markers, e.g., creatinine (Cr) and estimated glomerular filtration rate (eGFR), lack precision in early kidney disease detection. Neutrophil gelatinase-associated lipocalin (NGAL) has been proposed as a more sensitive biomarker for kidney injury. This study examined the effectiveness of plasma NGAL (pNGAL) as biomarker for CKD and AKI prediction in an emergency department (ED) setting and for predicting the presence of CKD and AKI in future admissions (readmission). The performance was compared to that of C-reactive protein (CRP).</p> Methods <p>A prospective longitudinal study was conducted at North Zealand University Hospital in Denmark, including 925 patients admitted to the ED. pNGAL and CRP were measured at admission, with follow-up pNGAL measurements for hospitalized patients. CKD and AKI were defined according to KDIGO guidelines. Receiver operating characteristic (ROC) analyses assessed the sensitivity, specificity, and predictive value of pNGAL and CRP, for AKI and CKD, at both admission and readmission.</p> Results and conclusion <p>pNGAL is useful for ruling out AKI and CKD, especially at admission, but its low PPV limit its diagnostic accuracy, particularly at readmission. It is more effective as a screening tool rather than a standalone diagnostic marker. Higher predictive performance was observed for pNGAL compared to CRP. For serial pNGAL measurements, CKD patients exhibited higher initial levels at admission, but these differences diminished by day four, with considerable variability observed thereafter.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A longitudinal prospective study investigating serial measurements of plasma neutrophil gelatinase-associated lipocalins (NGAL) for the prediction of chronic kidney disease and acute kidney injury in emergency department patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月30日

查看全文
  • Vicky Jenny Rebecka Wetterstrand,
  • Thomas Kallemose,
  • Jesper Juul Larsen,
  • Lennart Friis Hansen,
  • Lisbet Brandi

摘要

Background and hypothesis

Acute kidney injury (AKI) and chronic kidney disease (CKD) are associated with high morbidity. Current diagnostic markers, e.g., creatinine (Cr) and estimated glomerular filtration rate (eGFR), lack precision in early kidney disease detection. Neutrophil gelatinase-associated lipocalin (NGAL) has been proposed as a more sensitive biomarker for kidney injury. This study examined the effectiveness of plasma NGAL (pNGAL) as biomarker for CKD and AKI prediction in an emergency department (ED) setting and for predicting the presence of CKD and AKI in future admissions (readmission). The performance was compared to that of C-reactive protein (CRP).

Methods

A prospective longitudinal study was conducted at North Zealand University Hospital in Denmark, including 925 patients admitted to the ED. pNGAL and CRP were measured at admission, with follow-up pNGAL measurements for hospitalized patients. CKD and AKI were defined according to KDIGO guidelines. Receiver operating characteristic (ROC) analyses assessed the sensitivity, specificity, and predictive value of pNGAL and CRP, for AKI and CKD, at both admission and readmission.

Results and conclusion

pNGAL is useful for ruling out AKI and CKD, especially at admission, but its low PPV limit its diagnostic accuracy, particularly at readmission. It is more effective as a screening tool rather than a standalone diagnostic marker. Higher predictive performance was observed for pNGAL compared to CRP. For serial pNGAL measurements, CKD patients exhibited higher initial levels at admission, but these differences diminished by day four, with considerable variability observed thereafter.